Return on Assets (ROA)
since 2005
Calculation
Allergan PLC, ROA, long-term trends, calculation
| ROA | = | 100 | × | Net income (loss) attributable to shareholders1 | ÷ | Total assets1 | |
|---|---|---|---|---|---|---|---|
| Dec 31, 2019 | -5.57% | = | 100 | × | (5,271,000) | ÷ | 94,699,100) |
| Dec 31, 2018 | -5.01% | = | 100 | × | (5,096,400) | ÷ | 101,787,600) |
| Dec 31, 2017 | -3.49% | = | 100 | × | (4,125,500) | ÷ | 118,341,900) |
| Dec 31, 2016 | 11.61% | = | 100 | × | 14,973,400) | ÷ | 128,986,300) |
| Dec 31, 2015 | 2.88% | = | 100 | × | 3,915,200) | ÷ | 135,840,700) |
| Dec 31, 2014 | -3.10% | = | 100 | × | (1,630,500) | ÷ | 52,529,100) |
| Dec 31, 2013 | -3.30% | = | 100 | × | (750,400) | ÷ | 22,725,900) |
| Dec 31, 2012 | 0.69% | = | 100 | × | 97,300) | ÷ | 14,103,500) |
| Dec 31, 2011 | 3.90% | = | 100 | × | 260,900) | ÷ | 6,698,300) |
| Dec 31, 2010 | 3.16% | = | 100 | × | 184,400) | ÷ | 5,827,300) |
| Dec 31, 2009 | 3.70% | = | 100 | × | 222,000) | ÷ | 5,992,200) |
| Dec 31, 2008 | 6.48% | = | 100 | × | 238,379) | ÷ | 3,677,887) |
| Dec 31, 2007 | 4.06% | = | 100 | × | 141,030) | ÷ | 3,472,027) |
| Dec 31, 2006 | -11.83% | = | 100 | × | (445,005) | ÷ | 3,760,577) |
| Dec 31, 2005 | 4.49% | = | 100 | × | 138,233) | ÷ | 3,080,033) |
Based on: 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).
1 US$ in thousands
The Return on Assets (ROA) for Allergan PLC exhibited extreme volatility between 2005 and 2019, characterized by a transition from modest stability to a period of massive balance sheet expansion, followed by a sustained decline in profitability.
- Initial Stability and Volatility (2005–2011)
- During this period, the asset base remained relatively stable, fluctuating between $3.08 billion and $6.70 billion. ROA generally maintained a positive range between 3.16% and 6.48%, with the exception of a significant outlier in 2006, where a net loss of $445 million resulted in an ROA of -11.83%.
- Rapid Asset Expansion (2012–2015)
- A period of aggressive growth is observed starting in 2012, with total assets increasing from $14.10 billion to a peak of $135.84 billion by 2015. This expansion was accompanied by erratic net income performance, leading to negative ROA figures of -3.30% in 2013 and -3.10% in 2014, before recovering to 2.88% in 2015.
- Peak Performance (2016)
- The maximum ROA of 11.61% was achieved in 2016. This peak was driven by a substantial increase in net income attributable to shareholders, which reached $14.97 billion against a total asset base of $128.99 billion.
- Profitability Deterioration (2017–2019)
- A consistent downward trend in ROA is evident in the final three years of the sequence. Despite a gradual reduction in total assets from $118.34 billion in 2017 to $94.70 billion in 2019, net losses widened, reaching $5.27 billion in 2019. Consequently, ROA deteriorated steadily from -3.49% in 2017 to -5.57% in 2019.
AI Ask an analyst for more
Hi, I’m an AI-powered financial analyst at Stock Analysis on Net.
Without a user account, I tend to respond rather slowly.
How can I help you?
Comparison to Competitors
Allergan PLC, ROA, long-term trends, comparison to competitors
| Allergan PLC | AbbVie Inc. | Amgen Inc. | Bristol-Myers Squibb Co. | Danaher Corp. | Eli Lilly & Co. | Gilead Sciences Inc. | Johnson & Johnson | Merck & Co. Inc. | Pfizer Inc. | Regeneron Pharmaceuticals Inc. | Thermo Fisher Scientific Inc. | Vertex Pharmaceuticals Inc. | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec 31, 2019 | -5.57% | 8.84% | 13.13% | 2.65% | 4.85% | 21.17% | 8.74% | 9.59% | 11.66% | 9.72% | 14.29% | 6.33% | 14.15% |
| Dec 31, 2018 | -5.01% | 9.58% | 12.64% | 14.06% | 5.54% | 7.36% | 8.57% | 10.00% | 7.53% | 7.00% | 20.83% | 5.22% | 33.57% |
| Dec 31, 2017 | -3.49% | 7.50% | 2.48% | 3.00% | 5.34% | -0.45% | 6.58% | 0.83% | 2.72% | 12.40% | 13.67% | 3.93% | 7.43% |
| Dec 31, 2016 | 11.61% | 9.01% | 9.95% | 13.22% | 5.64% | 7.05% | 23.70% | 11.71% | 4.11% | 4.20% | 12.84% | 4.40% | -3.87% |
| Dec 31, 2015 | 2.88% | 9.70% | 9.69% | 4.93% | 6.96% | 6.77% | 34.93% | 11.55% | 4.36% | 4.16% | 11.34% | 4.83% | -22.26% |
| Dec 31, 2014 | -3.10% | 6.44% | 7.47% | 5.94% | 7.02% | 6.43% | 34.91% | 12.45% | 12.12% | 5.40% | 8.99% | 4.42% | -31.63% |
| Dec 31, 2013 | -3.30% | 14.14% | 7.68% | 6.64% | 7.77% | 13.29% | 13.67% | 10.42% | 4.17% | 12.78% | 14.38% | 4.00% | -19.19% |
| Dec 31, 2012 | 0.69% | 19.53% | 8.00% | 5.46% | 7.26% | 11.89% | 12.20% | 8.94% | 5.81% | 7.84% | 36.06% | 4.29% | -3.88% |
| Dec 31, 2011 | 3.90% | — | 7.54% | 11.25% | 7.25% | 12.92% | 16.20% | 8.51% | 5.97% | 5.32% | -16.75% | 4.96% | 1.34% |
| Dec 31, 2010 | 3.16% | — | 10.64% | 9.98% | 8.07% | 16.35% | 25.03% | 12.96% | 0.81% | 4.23% | -9.59% | 4.85% | -43.74% |
| Dec 31, 2009 | 3.70% | — | 11.62% | 34.22% | 5.88% | 15.76% | 27.18% | 12.95% | 11.51% | 4.05% | -9.15% | 3.93% | -32.84% |
| Dec 31, 2008 | 6.48% | — | 11.51% | 17.76% | 7.53% | -7.09% | 28.65% | 15.25% | 16.54% | 7.29% | -12.34% | 4.71% | -46.90% |
| Dec 31, 2007 | 4.06% | — | 9.14% | 8.27% | 7.84% | 11.02% | 27.68% | 13.06% | 6.77% | 7.07% | -11.28% | 3.59% | -65.05% |
| Dec 31, 2006 | -11.83% | — | 8.73% | 6.20% | 8.72% | 12.13% | -29.12% | 15.67% | 9.95% | 16.84% | -17.49% | 0.79% | -22.45% |
| Dec 31, 2005 | 4.49% | — | 12.54% | 10.66% | 9.80% | 8.05% | 21.62% | 17.94% | 10.33% | 6.88% | -22.54% | 5.25% | -37.05% |
Based on: 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).
Comparison to Sector (Pharmaceuticals, Biotechnology & Life Sciences)
Allergan PLC, ROA, long-term trends, comparison to sector (pharmaceuticals, biotechnology & life sciences)
| Allergan PLC | Pharmaceuticals, Biotechnology & Life Sciences | |
|---|---|---|
| Dec 31, 2019 | -5.57% | 9.02% |
| Dec 31, 2018 | -5.01% | 8.97% |
| Dec 31, 2017 | -3.49% | 5.28% |
| Dec 31, 2016 | 11.61% | 8.61% |
| Dec 31, 2015 | 2.88% | 8.93% |
| Dec 31, 2014 | -3.10% | 9.45% |
| Dec 31, 2013 | -3.30% | 9.46% |
| Dec 31, 2012 | 0.69% | 8.30% |
| Dec 31, 2011 | 3.90% | 7.30% |
| Dec 31, 2010 | 3.16% | 7.07% |
| Dec 31, 2009 | 3.70% | 10.02% |
| Dec 31, 2008 | 6.48% | 10.37% |
| Dec 31, 2007 | 4.06% | 8.86% |
| Dec 31, 2006 | -11.83% | 11.91% |
| Dec 31, 2005 | 4.49% | 10.42% |
Based on: 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).
Comparison to Industry (Health Care)
Allergan PLC, ROA, long-term trends, comparison to industry (health care)
| Allergan PLC | Health Care | |
|---|---|---|
| Dec 31, 2019 | -5.57% | 8.32% |
| Dec 31, 2018 | -5.01% | 7.90% |
| Dec 31, 2017 | -3.49% | 5.19% |
| Dec 31, 2016 | 11.61% | 7.31% |
| Dec 31, 2015 | 2.88% | 7.71% |
| Dec 31, 2014 | -3.10% | 8.59% |
| Dec 31, 2013 | -3.30% | 8.76% |
| Dec 31, 2012 | 0.69% | 8.09% |
| Dec 31, 2011 | 3.90% | 7.36% |
| Dec 31, 2010 | 3.16% | 7.24% |
| Dec 31, 2009 | 3.70% | 9.73% |
| Dec 31, 2008 | 6.48% | 9.50% |
| Dec 31, 2007 | 4.06% | 8.88% |
| Dec 31, 2006 | -11.83% | 10.52% |
| Dec 31, 2005 | 4.49% | 9.67% |
Based on: 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).